Skip to main content

Khosla Rachna's Form 4 filing

Amgen Inc (AMGN) · filed Jun 6, 2025

Accession no.
0001127602-25-017018
Filed
Jun 6, 2025
Trade date
Jun 5, 2025
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $434.5K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Khosla RachnaCIK 0001881332Officer (SVP, Business Development)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 5, 2025Common StockSSaleDisposed−1,500$289.68−$434,5208,162Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)